154 related articles for article (PubMed ID: 36960537)
1. Evaluation of Radiation Sensitivity Differences in Mouse Liver Tumor Organoids Using CRISPR/Cas9-Mediated Gene Mutation.
Jeon W; Jung SY; Lee CY; Kim WT; Kim H; Jang KW; Lim H; Lee M; Jeong DH; Kim SD; Kim IA; Choi SH; Son TG; Kim KS
Technol Cancer Res Treat; 2023; 22():15330338231165125. PubMed ID: 36960537
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-mediated direct mutation of cancer genes in the mouse liver.
Xue W; Chen S; Yin H; Tammela T; Papagiannakopoulos T; Joshi NS; Cai W; Yang G; Bronson R; Crowley DG; Zhang F; Anderson DG; Sharp PA; Jacks T
Nature; 2014 Oct; 514(7522):380-4. PubMed ID: 25119044
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
[TBL] [Abstract][Full Text] [Related]
4. Small extrachromosomal circular DNA harboring targeted tumor suppressor gene mutations supports intratumor heterogeneity in mouse liver cancer induced by multiplexed CRISPR/Cas9.
Guo T; Chen GQ; Li XF; Wang M; Liu KM; Yang XY; Liu SC; Feng YL; Liu PY; Lin H; Xie AY
Genome Med; 2023 Oct; 15(1):80. PubMed ID: 37803452
[TBL] [Abstract][Full Text] [Related]
5. Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast Organoids.
Dekkers JF; Whittle JR; Vaillant F; Chen HR; Dawson C; Liu K; Geurts MH; Herold MJ; Clevers H; Lindeman GJ; Visvader JE
J Natl Cancer Inst; 2020 May; 112(5):540-544. PubMed ID: 31589320
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.
Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B
Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360
[TBL] [Abstract][Full Text] [Related]
7. Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids.
Artegiani B; van Voorthuijsen L; Lindeboom RGH; Seinstra D; Heo I; Tapia P; López-Iglesias C; Postrach D; Dayton T; Oka R; Hu H; van Boxtel R; van Es JH; Offerhaus J; Peters PJ; van Rheenen J; Vermeulen M; Clevers H
Cell Stem Cell; 2019 Jun; 24(6):927-943.e6. PubMed ID: 31130514
[TBL] [Abstract][Full Text] [Related]
8. A Novel Rat Model of Nonalcoholic Fatty Liver Disease Constructed Through CRISPR/Cas-Based Hydrodynamic Injection.
Yu Q; Tan RZ; Gan Q; Zhong X; Wang YQ; Zhou J; Wang L
Mol Biotechnol; 2017 Oct; 59(9-10):365-373. PubMed ID: 28695481
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
10. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Chiu DK; Yuen VW; Cheu JW; Wei LL; Ting V; Fehlings M; Sumatoh H; Nardin A; Newell EW; Ng IO; Yau TC; Wong CM; Wong CC
Gastroenterology; 2020 Aug; 159(2):609-623. PubMed ID: 32275969
[TBL] [Abstract][Full Text] [Related]
12. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
[TBL] [Abstract][Full Text] [Related]
13. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
[TBL] [Abstract][Full Text] [Related]
14. Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.
Zhu W; Saw D; Weiss M; Sun Z; Wei M; Shaligram S; Wang S; Su H
Transl Stroke Res; 2019 Oct; 10(5):557-565. PubMed ID: 30511203
[TBL] [Abstract][Full Text] [Related]
15. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
16. A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer.
Merenda A; Andersson-Rolf A; Mustata RC; Li T; Kim H; Koo BK
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745625
[TBL] [Abstract][Full Text] [Related]
17. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively.
Zhou X; Li R; Jing R; Zuo B; Zheng Q
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1509-1521. PubMed ID: 32266537
[TBL] [Abstract][Full Text] [Related]
19. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.
Zhou J; Wang J; Shen B; Chen L; Su Y; Yang J; Zhang W; Tian X; Huang X
FEBS J; 2014 Apr; 281(7):1717-25. PubMed ID: 24494965
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system to disrupt the hepatitis B virus.
Zhen S; Hua L; Liu YH; Gao LC; Fu J; Wan DY; Dong LH; Song HF; Gao X
Gene Ther; 2015 May; 22(5):404-12. PubMed ID: 25652100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
